tiprankstipranks
BridgeBio Pharma Inc (DE:2CL)
XETRA:2CL
Germany Market

BridgeBio Pharma (2CL) Technical Analysis

3 Followers

Summary of all the Indicators

Overall Consensus
Sell
8Bullish
1Neutral
13Bearish
Technical Analysis Consensus
Buy
6Bullish
1Neutral
3Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
BridgeBio Pharma Inc’s (2CL) Moving Averages Convergence Divergence (MACD) indicator is -1.51, suggesting BridgeBio Pharma Inc is a Buy.
BridgeBio Pharma Inc’s (2CL) 20-Day exponential moving average is 67.62, while BridgeBio Pharma Inc’s (2CL) share price is €67.37, making it a Sell.
BridgeBio Pharma Inc’s (2CL) 50-Day exponential moving average is 67.80, while BridgeBio Pharma Inc’s (2CL) share price is €67.37, making it a Sell.

BridgeBio Pharma (2CL) Pivot Points

Sep 09, 2026, 03:22 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
63.96
63.96
63.96
63.96
63.96
63.96
63.96
Fibonacci
63.96
63.96
63.96
63.96
63.96
63.96
63.96
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

BridgeBio Pharma (2CL) Moving Averages

Sep 09, 2026, 03:22 AM
Period
Simple
Exponential
MA5
65.06Sell
65.00Sell
MA10
66.25Sell
66.13Sell
MA20
68.46Sell
67.62Sell
MA50
69.92Sell
67.80Sell
MA100
64.43Sell
65.68Sell
MA200
63.25Buy
62.55Buy
BridgeBio Pharma Inc’s (2CL) 10-Day exponential moving average is 66.13, while BridgeBio Pharma Inc’s (2CL) share price is €67.37, making it a Sell.
BridgeBio Pharma Inc’s (2CL) 100-Day exponential moving average is 65.68, while BridgeBio Pharma Inc’s (2CL) share price is €67.37, making it a Sell.
BridgeBio Pharma Inc’s (2CL) stock price is €67.37 and BridgeBio Pharma Inc’s (2CL) 50-day simple moving average is 69.92, creating a Sell signal.
BridgeBio Pharma Inc’s (2CL) stock price is €67.37 and BridgeBio Pharma Inc’s (2CL) 100-day simple moving average is 64.43, creating a Sell signal.
BridgeBio Pharma Inc’s (2CL) stock price is €67.37 and BridgeBio Pharma Inc’s (2CL) 200-day simple moving average is 63.25, creating a Buy signal.

BridgeBio Pharma (2CL) Technical Indicators

Sep 09, 2026, 03:22 AM
Name
Value
Implied Action
RSI (14)
36.30
Neutral
STOCH (9,6)
2.79
Buy
STOCHRSI (14)
1.60
Buy
MACD (12,26)
-1.51
Buy
ADX (14)
16.93
Buy
Williams %R
-95.19
Buy
CCI (14)
-104.34
Buy
ATR (14)
1.21
-
Ultimate Oscillator
25.11
Sell
ROC
-5.35
Sell
BridgeBio Pharma Inc’s (2CL) Relative Strength Index (RSI) is 36.30, creating a Neutral signal.
BridgeBio Pharma Inc’s (2CL) Trend Strength Indicator (ADX) is 16.93, creating a Buy signal.
BridgeBio Pharma Inc’s (2CL) Commodity Channel Index (CCI) is -104.34, creating a Buy signal.
BridgeBio Pharma Inc’s (2CL) Price Rate of Change (ROC) is -5.35, creating a Sell signal.

FAQ

Is 2CL a Buy, Hold, or Sell?
Based on 2CL’s technical indicators, 2CL is a Sell.
    What is 2CL’s RSI (14)?
    2CL’s RSI (14) is 36.30, which suggests 2CL is a Neutral.
      What is 2CL’s MACD?
      2CL’s MACD is -1.51, which suggests 2CL is a Buy.
        What is 2CL’s 5-day moving average?
        2CL’s 5-day moving average is 65.06, which suggests 2CL is a Sell.
          What is 2CL’s 20-day moving average?
          2CL 20-day moving average is 68.46, which suggests 2CL is a Sell.
            What is 2CL’s 50-day moving average?
            2CL’s 50-day moving average is 69.92, which suggests 2CL is a Sell.
              What is 2CL’s 200-day moving average?
              2CL’s 200-day moving average is 63.25, which suggests 2CL is a Buy.
                What is 2CL’s Williams % R (14)?
                2CL’s Williams % R (14) is -95.19, which suggests 2CL is a Buy.
                  What is 2CL’s CCI (14)?
                  2CL’s CCI (14) is -104.34, which suggests 2CL is a Buy.
                    What is the share price of BridgeBio Pharma Inc?